Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer [Phase 1]
Phase 1 trial evaluating the combination of Cirtuvivint and Olaparib for BRCA/Homologous Recombination Deficiency–related platinum-resistant…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer [Phase 1, Phase 2]
TORL Biotherapeutics is conducting a Phase 1/2 trial (CATALINA-4) to evaluate the safety and initial efficacy of TORL-1-23 given with chemot…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study [NA]
Life on the Go 3 is an automated, personalized physical activity program being studied to improve immune function and clinical outcomes in w…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian [Phase 1]
A Phase 1 study investigating AZD2014 (an mTORC1/2 inhibitor) or AZD5363 (an AKT inhibitor) in recurrent endometrial and ovarian cancers, wi…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. [Phase 2]
A Phase 2 clinical study of TORL-1-23 is evaluating its activity in platinum-resistant ovarian cancer. The trial is currently recruiting acr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) [Phase 1, Phase 2]
This Phase 1/2 study tests durvalumab in combination with chemotherapy as frontline treatment for ovarian cancer and related gynecologic can…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating paclitaxel delivered via pressurized intraperitoneal aerosol chemotherapy for platinum-resistant re…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance
A ClinicalTrials.gov update describes a study evaluating how dietary patterns affect prognosis for ovarian cancer patients during PARP inhib…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers [Phase 1, Phase 2]
Regeneron is conducting a Phase 1/2 trial of REGN4018 (Ubamatamab) alone or in combination with cemiplimab in adults with recurrent MUC16-ex…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial investigating the combination of vismodegib and atezolizumab in platinum-resistant ovarian, fallopian tube, and primary peri…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for BL-M17D1 in patients with HER2-expressing or HER2-mutant advanced or metastatic solid tumors; the study is…
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. [Phase 1, Phase 2]
A Phase 1a/1b clinical trial evaluating TILT-123 (oncolytic adenovirus) with pembrolizumab, and with pegylated liposomal doxorubicin, for pl…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating mirvetuximab soravtansine with carboplatin for FRα-expressing, platinum-sensitive epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating senaparib in combination with temozolomide for ARID1A mutation–associated ovarian cancer and related perit…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: A Study of Sovilnesib in Subjects With Ovarian Cancer [Phase 1]
Phase 1 study update of Sovilnesib in gynecologic cancers; the trial is active but not recruiting, investigating high-grade serous ovarian c…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial [Phase 2]
Phase 2 trial evaluating Folate Receptor Alpha Dendritic Cells (FRαDCs) vs placebo for stage III/IV ovarian, fallopian tube, or primary peri…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) [Phase 3]
Phase 3 trial MATAO is evaluating maintenance therapy with an aromatase inhibitor in epithelial ovarian cancers; the study is currently recr…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating pembrolizumab in combination with the DPX-Survivac vaccine and cyclophosphamide for advanced ova…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with carboplatin for recurrent ovarian cancer, fallopian tube cancer, or primary perit…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer [Phase 3]
A Phase 3 trial comparing niraparib alone to niraparib plus bevacizumab in advanced ovarian, fallopian tube, and peritoneal cancers is curre…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial is evaluating first-line treatment with carboplatin plus mirvetuximab soravtansine for advanced-stage ovarian, fallopian tub…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers [Phase 2]
Phase 2 clinical trial update evaluating cryocompression with or without cilostazol to prevent paclitaxel-induced neuropathy in gynecologic …
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for TRK-950 in combination with anti-cancer regimens in patients with advanced solid tumors; the study is active but no…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Abemaciclib for recurrent gynecologic cancers, including endometrial, fallopian tube, ovarian, and pr…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer [Phase 2]
Phase 2 trial evaluating body surface area-based dosing versus concentration-based dosing of cisplatin for HIPEC in women with advanced ovar…